Upbeat sales in Hoka, Ugg brands prompt a boost to outlook at Deckers
By Emily Bary
Deckers raises its profit forecast for the year and mentions 'robust full-price demand' for its Hoka and Ugg brands
Upbeat results from the Hoka and Ugg brands prompted Deckers Outdoors Corp. to boost its full-year profit outlook on Thursday.
The shoe company now expects $29.75 to $30.65 in earnings per share for the full fiscal year, while its prior forecast called for $29.50 to $30.00. Deckers (DECK) kept intact its sales outlook, which called for $4.7 billion.
For the fiscal first quarter that just wrapped up, Deckers logged net income of $115.6 million, or $4.52 a share, up from $63.6 billion, or $2.41 a share, in the year-earlier period. That was well above the $3.49 a share that analysts were modeling.
Shares of Deckers rose 10% in Thursday's aftermarket action.
Read: Skechers shares rise on $1 billion buyback, more upbeat outlook
Deckers booked a 22.1% rise in revenue for the latest quarter, coming in at $825.3 million. Analysts tracked by FactSet were looking for $808.4 million.
The company saw 29.7% growth in Hoka brand net sales, reaching $545.2 million. Revenue from the Ugg category rose 14.0% to $223.0 million. Deckers saw Teva brand sales fall 4.3% to $46.3 million.
The revenue from Hoka and Ugg topped expectations, which were for $536.6 million and $219.8 million, respectively. The consensus view on Teva was for $47.3 million in sales.
"Hoka and Ugg continue to drive robust full-price demand in the global marketplace by delivering compelling product that consumers love," said Dave Powers, the company's outgoing chief executive.
See also: Lululemon's stock gets a downgrade as spending on activewear slows further
-Emily Bary
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-25-24 2012ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks